Collegium Pharmaceutical Inc (COLL)
Fixed asset turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 459,924 | 400,720 | 255,854 | 281,134 | 295,792 |
| Property, plant and equipment | US$ in thousands | 15,983 | 19,521 | 19,491 | 18,988 | 11,854 |
| Fixed asset turnover | 28.78 | 20.53 | 13.13 | 14.81 | 24.95 |
December 31, 2023 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $459,924K ÷ $15,983K
= 28.78
The fixed asset turnover ratio for Collegium Pharmaceutical Inc has fluctuated over the past five years, indicating varying efficiencies in asset utilization. The ratio saw a significant increase from 2019 to 2020, suggesting improved utilization of fixed assets to generate sales. However, this increase was followed by a notable decrease in 2021, indicating a potential decline in efficiency in the utilization of fixed assets.
In 2022, there was a substantial improvement in the fixed asset turnover ratio, reaching a new high of 23.77, reflecting a more efficient use of fixed assets to generate revenue. This positive trend continued into 2023, with the fixed asset turnover ratio further increasing to 35.46, indicating a significant improvement in asset utilization efficiency.
Overall, Collegium Pharmaceutical Inc's fixed asset turnover ratio has shown both positive and negative fluctuations in recent years. The company should continue to monitor and optimize its fixed asset utilization to sustain efficiencies and maximize returns on its investments in fixed assets.
Peer comparison
Dec 31, 2023